27,855 Docusign Inc. $DOCU Shares Bought by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC increased its stake in shares of Docusign Inc. (NASDAQ:DOCU) by 30.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,835 shares of the company’s stock after buying an additional 27,855 shares during the period. Greenwich Wealth Management LLC owned about 0.06% of Docusign worth $5,367,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Bank of America Corp DE lifted its holdings in shares of Docusign by 23.3% in the first quarter. Bank of America Corp DE now owns 1,193,163 shares of the company’s stock worth $56,568,000 after buying an additional 225,801 shares in the last quarter. Capital World Investors increased its holdings in Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after acquiring an additional 1,603,900 shares during the period. Assenagon Asset Management S.A. increased its holdings in Docusign by 247.5% during the 2nd quarter. Assenagon Asset Management S.A. now owns 349,038 shares of the company’s stock worth $15,504,000 after acquiring an additional 248,597 shares during the period. Los Angeles Capital Management LLC purchased a new stake in Docusign in the 4th quarter worth approximately $1,750,000. Finally, OP Asset Management Ltd bought a new position in Docusign in the 1st quarter valued at $3,931,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Docusign Price Performance

NASDAQ DOCU traded down $0.27 on Tuesday, reaching $66.71. 581,344 shares of the company’s stock traded hands, compared to its average volume of 4,059,076. The stock has a market cap of $12.47 billion, a PE ratio of 40.75, a P/E/G ratio of 2.54 and a beta of 0.90. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $81.88. The stock has a 50-day simple moving average of $61.99 and a 200 day simple moving average of $52.43.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The firm had revenue of $875.75 million during the quarter, compared to analyst estimates of $867.22 million. During the same period in the previous year, the business posted $0.30 EPS. The business’s quarterly revenue was up 9.4% on a year-over-year basis. As a group, analysts anticipate that Docusign Inc. will post 2.1 EPS for the current year.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks raised several long-term earnings forecasts. FY2027 EPS was increased to $1.96 from $1.69, FY2028 EPS to $2.07 from $1.76, and FY2029 EPS to $1.95 from $1.35. Zacks also lifted estimates for Q1 2028, Q2 2028, Q3 2028 and Q2 2029, signaling improved expectations for Docusign’s profitability. Docusign Stock Earnings Estimates Lifted by Zacks Research
• Positive Sentiment: Zacks identified Docusign as a long-term momentum stock. Its style-score analysis highlights the company’s favorable momentum characteristics, which may support investor interest if earnings growth continues. Why DocuSign is a Top Momentum Stock for the Long-Term
• Neutral Sentiment: The revisions were mixed. Zacks raised its Q2 2029 EPS estimate to $0.67 from $0.21, but lowered Q1 2029 EPS to $0.66 from $0.73 and Q4 2028 EPS to $0.57 from $0.62. The conflicting changes may have limited the immediate bullish impact.
• Negative Sentiment: Most of the positive revisions are distant. Investors may be focusing more on current and upcoming results than forecasts extending through FY2029. Docusign’s prior quarter showed solid execution—$1.16 EPS versus a $1.09 estimate and 9.4% year-over-year revenue growth—but the stock’s elevated valuation leaves less room for disappointment.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on DOCU. BTIG Research upped their price target on shares of Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. Evercore set a $65.00 target price on Docusign in a research note on Friday, September 4th. Morgan Stanley raised their price target on Docusign from $69.00 to $75.00 and gave the company an “equal weight” rating in a report on Friday, September 4th. Royal Bank Of Canada lifted their price target on Docusign from $55.00 to $70.00 and gave the company a “sector perform” rating in a research report on Friday, September 4th. Finally, Bank of America upped their price objective on shares of Docusign from $58.00 to $64.00 and gave the stock an “underperform” rating in a research report on Friday, September 4th. Three investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Docusign presently has an average rating of “Hold” and an average target price of $67.33.

Insiders Place Their Bets

In other news, Director Teresa Briggs sold 548 shares of Docusign stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $64.60, for a total value of $35,400.80. Following the transaction, the director owned 10,811 shares in the company, valued at approximately $698,390.60. The trade was a 4.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Peter Solvik sold 46,000 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $65.24, for a total value of $3,001,040.00. Following the completion of the sale, the director directly owned 49,558 shares of the company’s stock, valued at approximately $3,233,163.92. This trade represents a 48.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 182,568 shares of company stock valued at $10,892,550 over the last three months. 0.59% of the stock is currently owned by company insiders.

About Docusign

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company’s products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.